Skip to main content
NIH funding notice RFA-CA-13-002

Validation and Advanced Development of Emerging Molecular Analysis Technologies for Cancer Research (R33)

Closed on September 20, 2013.

Posted
November 9, 2012
Close date
September 20, 2013
Activity codes
R33
Institutes taking part
NCI

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

  1. Reissues: RFA-CA-12-003 Validation and Advanced Development of Emerging Technologies for Cancer Research (R33)
  2. 2 steps back: RFA-CA-10-004 Validation and Advanced Development of Emerging Technologies for Cancer Research (R33)
  3. 3 steps back: RFA-CA-09-007 Application and Use of Transformative Emerging Technologies in Cancer Research (R33)
  4. 4 steps back: RFA-CA-08-008
  5. 5 steps back: RFA-CA-07-036
  6. 6 steps back: RFA-CA-07-018
  7. 7 steps back: RFA-CA-07-002
  8. 8 steps back: RFA-CA-06-003
  9. 9 steps back: RFA-CA-05-003

Replaced by RFA-CA-14-004.

Who won it before

6 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,271,506 in first-year total cost, median $379,966.

Most frequent study sections

  1. Special Emphasis Panel[ZCA1 SRLB-Q (J2)]4
  2. Special Emphasis Panel[ZCA1 SRLB-Q (M2)]2

Most frequent institutions

  1. MAYO CLINIC ROCHESTER1
  2. STANFORD UNIVERSITY1
  3. UNIVERSITY OF CALIFORNIA, SAN DIEGO1
  4. UNIVERSITY OF CALIFORNIA, SAN FRANCISCO1
  5. UNIVERSITY OF MINNESOTA1
Competing awards under RFA-CA-13-002 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2014Integrating mass cytometric and transcriptomic profiles of solid tumors1R33CA183692-01WEISS, WILLIAM AUNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA$408,712ZCA1
2014Large-Scale Characterization of Anti-Cancer Antibody Responses in Lung Adenocarci1R33CA183659-01ROBINSON, WILLIAM HSTANFORD UNIVERSITY, CA$399,643ZCA1
2014Validation and Advanced Development of Duplex Sequencing1R33CA181771-01A1LOEB, LAWRENCE AUNIVERSITY OF WASHINGTON, WA$384,923ZCA1
2014Validating Technology To Optimize Antibody Affinity For Targeting Therapeutics1R33CA177333-01A1FEDERSPIEL, MARK JMAYO CLINIC ROCHESTER, MN$375,008ZCA1
2014Non-Circulating Microparticles for Improved Localization and Resection Cancer1R33CA177449-01A1BLAIR, SARAH LUNIVERSITY OF CALIFORNIA, SAN DIEGO, CA$361,766ZCA1
2014Multiplexed Kinase Biosensor Technology to Detect Leukemia Signaling with Mass Sp1R33CA183671-01PARKER, LAURIE L.UNIVERSITY OF MINNESOTA, MN$341,454ZCA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-CA-13-002: Validation and Advanced Development of Emerging Molecular Analysis Technologies for Cancer Research (R33) | ScienceDex | ConductScience